• GIRENTUXIMAB chembl:CHEMBL1743027 Antineoplastic

    Alternate Names:

    WX-G250
    RENCAREX
    GIRENTUXIMAB
    CA9-SCAN CG250
    CG-250

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 7.97

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name WX-G250,Rencarex
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 5.32

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Mechanism of Interaction Carbonic anhydrase IX other
    Direct Interaction yes

    PMIDs:
    None found